In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Torik Ayoubi Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Torik
Last Name:Ayoubi
Title:Dr.
Advanced Degrees:PhD
Affiliation:KU Leuven
Department:Center for Human Genetics
Street Address 1:O&N1 Herestraat 49 box 602
City:Leuven
Zip/Postal Code:3000
Country/Territory:Belgium
Phone:0032-16330581
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 22 February 2011]
Clinical Interests:
Alzheimer Disease, Neurodevelopmental Disorders (Down syndrome, etc.), Tauopathies, Neuromuscular Disorders (ALS, etc.), Polyglutamine Disorders (Huntington's, etc.), Aging Process, Parkinson Disease
Research Focus:
A-beta PP/A-beta, Microscopy, Neurobiology, Diagnosis, DNA microarrays, Proteomics, Tau/Cytoskeleton, Stem cells, Molecular and Cell biology, Oxidative Stress, Genetics, Neuroimmunology, Neuropathology, Bioinformatics/Statistics
Work Sector(s):
Research institute
Web Sites:
Personal: http://biomedicalgenomics.org/
Professional: http://www.kuleuven.be/english/
Lab: http://med.kuleuven.be/cme/subpage.html?section=laboratories&subsection=laboratory-for-the-research-of-neurodegenerative-diseases&en
Researcher Bio
My expertise centers around Genomics Research. In particular, the study of genome dynamics by analyzing the transcriptome of cells and tissues using DNA Gene Expression Microarrays and Next Generation Sequencing technologies.
Top Papers
Functional annotation of heart enriched mitochondrial genes GBAS and CHCHD10 through guilt by association.
Martherus RS, Sluiter W, Timmer ED, VanHerle SJ, Smeets HJ, Ayoubi TA.
Biochem Biophys Res Commun. 2010 Nov 12;402(2):203-8. Epub 2010 Oct 1.
PMID:20888800

The ATF6-Met[67]Val substitution is associated with increased plasma cholesterol levels.
Meex SJ, Weissglas-Volkov D, van der Kallen CJ, Thuerauf DJ, van Greevenbroek MM, Schalkwijk CG, Stehouwer CD, Feskens EJ, Heldens L, Ayoubi TA, Hofker MH, Wouters BG, Vlietinck R, Sinsheimer JS, Taskinen MR, Kuusisto J, Laakso M, de Bruin TW, Pajukanta P, Glembotski CC.
Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1322-7. Epub 2009 Aug 10.
PMID:19667116

Activating transcription factor 6 polymorphisms and haplotypes are associated with impaired glucose homeostasis and type 2 diabetes in Dutch Caucasians.
Meex SJ, van Greevenbroek MM, Ayoubi TA, Vlietinck R, van Vliet-Ostaptchouk JV, Hofker MH, Vermeulen VM, Schalkwijk CG, Feskens EJ, Boer JM, Stehouwer CD, van der Kallen CJ, de Bruin TW.
J Clin Endocrinol Metab. 2007 Jul;92(7):2720-5. Epub 2007 Apr 17.
PMID:17440018

Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development.
Ayoubi TA, Jansen E, Meulemans SM, Van de Ven WJ.
Oncogene. 1999 Sep 9;18(36):5076-87.
PMID:10490844

Cell type-specific protein-DNA interactions at the cAMP response elements of the prohormone convertase 1 promoter. Evidence for additional transactivators distinct from CREB/ATF family members.
Jansen E, Ayoubi TA, Meulemans SM, Van de Ven WJ.
J Biol Chem. 1997 Jan 24;272(4):2500-8.
PMID:8999965

Genomic organization of the human NSP gene, prototype of a novel gene family encoding reticulons.
Roebroek AJ, Ayoubi TA, Van de Velde HJ, Schoenmakers EF, Pauli IG, Van de Ven WJ.
Genomics. 1996 Mar 1;32(2):191-9.
PMID:8833145

Regulation of gene expression by alternative promoters.
Ayoubi TA, Van De Ven WJ.
FASEB J. 1996 Mar;10(4):453-60. Review.
PMID:8647344

Expression of the dibasic proprotein processing enzyme furin is directed by multiple promoters.
Ayoubi TA, Creemers JW, Roebroek AJ, Van de Ven WJ.
J Biol Chem. 1994 Mar 25;269(12):9298-303.
PMID:8132667

Transcriptional and posttranscriptional regulation of the proopiomelanocortin gene in the pars intermedia of the pituitary gland of Xenopus laevis.
Ayoubi TA, Jenks BG, Roubos EW, Martens GJ.
Endocrinology. 1992 Jun;130(6):3560-6.
PMID:1597153

The neuroendocrine polypeptide 7B2 is a precursor protein.
Ayoubi TA, van Duijnhoven HL, van de Ven WJ, Jenks BG, Roubos EW, Martens GJ.
J Biol Chem. 1990 Sep 15;265(26):15644-7.
PMID:2394742
What is the greatest void to date in our knowledge of Alzheimer's Disease?
Why the late onset (aging required)
If resources were not limited, what research projects would you pursue?
First gene expression changes in blood that indicate that a patient will develop a neurodegenerative disorder.
What is your leading hypothesis?
The pathology in the brain will be "communicated" to immune cells in bonemarrow, which will respond to the disease process.
What piece of missing evidence would help prove it?
Deatailed gene expression analysis of fractionated blood cells in order to identify the small fraction of responding cells on their way to the "injured" brain.
What is your fallback position?
No fallback required. Neurodegenerated brains are inriched in immune cells and they hav to get there from the bonemarrow. If recourced were unlimited I will identify them on their way to the brain.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad